arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ZIMMER BIOMET HOLDINGS, INC.

ZBH
$96.61 ▼ -0.57 (-0.59%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
73 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

ZIMMER BIOMET HOLDINGS, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $18.8B
Dividend Yield 0.25%
Revenue Growth 9.3%
Op. Margin 17.9%
ROIC 1.6%
FCF / Share $1.66
Trailing P/E 79.2x
Price / Book 1.5x
FCF Yield 1.7%
Debt / Equity 0.50
info Valuation on last close. End-of-day price, Aug 7, 2026.

73-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.09B
↑ +9.3%
Net Income Profit after all expenses
$238.10M
↑ +30.8%
Operating Margin Operating profit as % of sales
17.9%
↑ +159.7% 64th
FCF / Share Free cash flow per share
$1.66
↓ -2.6%
Long-Term Debt Long-term obligations
$6.30B
↓ -9.2%

Health Breakdown

Profitability
68
Returns
55
Financial Health
58
Cash Quality
87

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+0.0% YoY
+0.8% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 73 quarters